ArticleBMC neurology2023

Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates.

Daphne H Schoenmakers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.